Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
52,124,856
-
Shares change
-
-987,403
-
Total reported value, excl. options
-
$1,684,666,056
-
Value change
-
-$42,369,690
-
Number of buys
-
93
-
Number of sells
-
-84
-
Price
-
$32.32
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2015
193 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q3 2015.
HAEMONETICS CORP - Common Stock (HAE) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52,124,856 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3,772,679 shares), Neuberger Berman Group LLC (3,717,686 shares), BlackRock Fund Advisors (3,061,460 shares), WELLS FARGO & COMPANY/MN (2,436,384 shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (2,239,841 shares), Black Creek Investment Management Inc. (2,035,491 shares), FMR LLC (1,927,926 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,851,127 shares), WESTWOOD HOLDINGS GROUP INC (1,847,468 shares), and WELLINGTON MANAGEMENT GROUP LLP (1,488,436 shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.